Default: Cancer Biology and Medicine

ISSN: 2095-3941

Journal Home

Journal Guideline

Cancer Biology and Medicine Q1 Unclaimed

Chinese Anticancer Association China
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Biology and Medicine is a journal indexed in SJR in Oncology and Cancer Research with an H index of 62. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1350 €. The scope of the journal is focused on cancer genetics, oncology clinical trials, targeted therapy and immunology, cancer and stem cell biology, cancer prevention and epidemiology, cancer biomarkers. It has an SJR impact factor of 1,575 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,575.

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

1350 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Cancer Biology and Medicine

1,575

SJR Impact factor

62

H Index

73

Total Docs (Last Year)

293

Total Docs (3 years)

4508

Total Refs

1597

Total Cites (3 years)

288

Citable Docs (3 years)

4.43

Cites/Doc (2 years)

61.75

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


Cancer genetics Oncology clinical trials Targeted therapy and immunology Cancer and stem cell biology Cancer prevention and epidemiology Cancer biomarkers



Best articles by citations

Comparison of sentinel lymph node detection performances using blue dye in conjunction with indocyanine green or radioisotope in breast cancer patients: a prospective single-center randomized study

View more

A new combined criterion to better predict malignant lesions in patients with pancreatic cystic neoplasms

View more

Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang

View more

Ovarian cancer presenting with hypercalcemia: two cases with similar manifestations but different mechanisms

View more

Modulation of B-cell receptor and microenvironment signaling by a guanine exchange factor in B-cell malignancies

View more

Factors associated with upstaging in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy

View more

Extracranial metastasis of anaplastic oligoastrocytoma

View more

Key questions about the checkpoint blockade-are microRNAs an answer?

View more

Changing paradigm of cancer therapy: precision medicine by next-generation sequencing

View more

Establishment and application of a multiplex genetic mutation-detection method of lung cancer based on MassARRAY platform

View more

The oncofetal protein IMP3 is an indicator of early recurrence and poor outcome in mucoepidermoid carcinoma of salivary glands

View more

Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

View more
SHOW MORE ARTICLES

Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment

View more

Modified Blumgart anastomosis without pancreatic duct-to-jejunum mucosa anastomosis for pancreatoduodenectomy: a feasible and safe novel technique

View more

Dorsomorphin induces cancer cell apoptosis and sensitizes cancer cells to HSP90 and proteasome inhibitors by reducing nuclear heat shock factor 1 levels

View more

Advances in caring for the older cancer patient: a report from the 2015 conference of the International Society of Geriatric Oncology

View more

Aggressive primary hepatic epithelioid hemangioendothelioma: a case report and literature review

View more

Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer

View more

Multidisciplinary team for the diagnosis and treatment of 2 cases of primary intestinal yolk sac tumor

View more

Brain metastasis in non-small cell lung cancer (NSCLC) patients with uncommon EGFR mutations: a report of seven cases and literature review

View more

Calcium channel a2d1 subunit as a novel biomarker for diagnosis of hepatocellular carcinoma

View more

Immunosuppressive checkpoint Siglec-15: a vital new piece of the cancer immunotherapy jigsaw puzzle

View more

The next generation of cancer management

View more

Attenuated plasmodium sporozoite expressing MAGE-A3 induces antigen-specific CD8+ T cell response against lung cancer in mice

View more

FAQS